Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/27/18 → 05/23/20 |
Funding
- Castle Creek Pharmaceuticals LLC: $8,375.00
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2/3 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)
- Slutsky, Jordan (PI)
- Kaufmann, Tara (CoPI)
- Lozeau, Daniel (CoPI)
- Silverstein, David (CoPI)
Project: Research